Elements of latent learning in a maze environment

A general purpose learning program is described which demonstrates a latent learning ability by operating at two separate goal pursuit levels. At one level are the constant, implicit goals associated with the system's memory management mechanisms. At the higher level are the dynamic, explicit behavioral goals which the implicit goals enable by manipulating memory representations to conform to the external surroundings. The program is shown to negotiate a simulated maze environment by the step-wise refinement of its latently learned experiences

Learning and memory in machines and animals : an AI model that accounts for some neurobiological data

The CEL model of learning and memory (Components of Episodic Learning) [Granger 1982, 1983a, 1983b] provides a process model of certain aspects of learning and memory in animals and humans. The model consists of a set of asynchronous and semi-independent functional operators that collectively create and modify memory traces as a result of experience. The model conforms to relevant results in the learning literature of psychology and neurobiology. There are two goals to this work: one is to create a set of working learning systems that will improve their performance on the basis of experience, and the other is to compare these systems' performance with that of living systems, as a step towards the eventual comparative characterizations of different learning systems.Parts of the model have been implemented in the CEL-0 program, which operates in a 'Maze-World' simulated maze environment. The program exhibits simple exploratory behavior that leads to the acquisition of predictive and discriminatory schemata. A number of interesting theoretical predictions have arisen in part from observation of the operation of the program, some of which are currently being tested in neurobiological experiments. In particular, some neurobiological evidence for the existence of multiple, seperable memory systems in humans and animals is interpreted in terms of the model, and some new experiments are suggested arising from the model's predictions

An experimental and analytical investigation of isolated rotor flap-lag stability in forward flight

For flap-lag stability of isolated rotors, experimental and analytical investigations are conducted in hover and forward flight on the adequacy of a linear quasisteady aerodynamics theory with dynamic inflow. Forward flight effects on lag regressing mode are emphasized. A soft inplane hingeless rotor with three blades is tested at advance ratios as high as 0.55 and at shaft angles as high as 20 degrees. In combination with lag natural frequencies, collective pitch settings and flap-lag coupling parameters, the data base comprises nearly 1200 test points (damping and frequency) in forward flight and 200 test points in hover. By computerized symbolic manipulations, an analytic model is developed in substall to predict stability margins with mode identification. It also predicts substall and stall regions to help explain the correlation between theory and data

FGFR2 amplification in colorectal adenocarcinoma

FGFR2 is recurrently amplified in 5% of gastric cancers and 1%–4% of breast cancers; however, this molecular alteration has never been reported in a primary colorectal cancer specimen. Preclinical studies indicate that several FGFR tyrosine-kinase inhibitors (TKIs), such as AZD4547, have in vitro activity against the FGFR2-amplified colorectal cell line, NCI-H716. The efficacy of these inhibitors is currently under investigation in clinical trials for breast and gastric cancer. Thus, better characterizing colorectal tumors for FGFR2 amplification could identify a subset of patients who may benefit from FGFR TKI therapies. Here, we describe a novel FGFR2 amplification identified by clinical next-generation sequencing in a primary colorectal cancer. Further characterization of the tumor by immunohistochemistry showed neuroendocrine differentiation, similar to the reported properties of the NCI-H716 cell line. These findings demonstrate that the spectrum of potentially clinically actionable mutations detected by targeted clinical sequencing panels is not limited to only single-nucleotide polymorphisms and insertions/deletions but also to copy-number alterations.</jats:p

Developing and testing accelerated partner therapy for partner notification for people with genital Chlamydia trachomatis diagnosed in primary care: a pilot randomised controlled trial

Background Accelerated partner therapy (APT) is a promising partner notification (PN) intervention in specialist sexual health clinic attenders. To address its applicability in primary care, we undertook a pilot randomised controlled trial (RCT) of two APT models in community settings. Methods Three-arm pilot RCT of two adjunct APT interventions: APTHotline (telephone assessment of partner(s) plus standard PN) and APTPharmacy (community pharmacist assessment of partner(s) plus routine PN), versus standard PN alone (patient referral). Index patients were women diagnosed with genital chlamydia in 12 general practices and three community contraception and sexual health (CASH) services in London and south coast of England, randomised between 1 September 2011 and 31 July 2013. Results 199 women described 339 male partners, of whom 313 were reported by the index as contactable. The proportions of contactable partners considered treated within 6 weeks of index diagnosis were APTHotline 39/111 (35%), APTPharmacy 46/100 (46%), standard patient referral 46/102 (45%). Among treated partners, 8/39 (21%) in APTHotline arm were treated via hotline and 14/46 (30%) in APTPharmacy arm were treated via pharmacy. Conclusions The two novel primary care APT models were acceptable, feasible, compliant with regulations and capable of achieving acceptable outcomes within a pilot RCT but intervention uptake was low. Although addition of these interventions to standard PN did not result in a difference between arms, overall PN uptake was higher than previously reported in similar settings, probably as a result of introducing a formal evaluation. Recruitment to an individually randomised trial proved challenging and full evaluation will likely require service-level randomisation

Nature or nurture BMI and blood pressure at 90. Findings from the Belfast Elderly longitudinal free-living aging study Belfast

Hypertension is a key risk factor for stroke, cardiovascular disease and dementia. Although the link between weight, sodium and hypertension is established in younger people, little is known about their inter-relationship in people beyond 80 years of age. Associations between blood pressure, anthropometric indices and sodium were investigated in 495 apparently healthy, community-living participants (age 90, SD 4.8; range 80–106), from the cross-sectional Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST) study. In age-sex-adjusted logistic regression models, blood pressure =140/90 mmHg significantly associated with body mass index (BMI) [odds ratio (OR)?=?1.28/ kg/m2], with weight (OR?=?1.22/kg) approaching significance (P?=?0.07). In further age-sex-adjusted models, blood pressure above the 120/80 mmHg normotensive reference value significantly associated with BMI (OR?=?1.44/kg/m2), weight (OR?=?1.36/kg), skin-fold-thickness (OR?=?1.33/mm) and serum sodium (OR?=?1.37 mmol/l). In BELFAST participants over 80 years old, blood pressure =140/90 mmHg is associated with BMI, in apparently similar ways to younger groups

Strain dependence of bonding and hybridization across the metal-insulator transition of VO2

Soft x-ray spectroscopy is used to investigate the strain dependence of the metal-insulator transition of VO2. Changes in the strength of the V 3d - O 2p hybridization are observed across the transition, and are linked to the structural distortion. Furthermore, although the V-V dimerization is well-described by dynamical mean-field theory, the V-O hybridization is found to have an unexpectedly strong dependence on strain that is not predicted by band theory, emphasizing the relevance of the O ion to the physics of VO2